EUVIMEDEUVIMED entdecken
Multizentrische Studie

Longitudinal changes in tumor morphology and body composition following neoadjuvant chemotherapy predict progression-free survival in adenocarcinoma of the esophagogastric junction: A multi-center study

Chenglong Luo, Wanling Mu, Haojie Zhang, Xinhua Meng, Youxin Zhang, Yusai Mu, Mengchen Yuan, Yue Zhou, Liming Li, Changmao Ding, Xuejun Chen, Ming Li und 2 weitere

European Journal of Radiology · 2025

DOI: 10.1016/j.ejrad.2025.112461 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Radiology, 2025. Verfasst von Chenglong Luo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052 Henan Province, China. Hauptthemen laut MEDLINE: Esophagogastric Junction, Neoadjuvant Therapy, Esophageal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhengzhou Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to investigate the predictive value of longitudinal changes in tumor morphology and body composition during neoadjuvant chemotherapy (NAC) for progression-free survival (PFS) following radical resection of adenocarcinoma of the esophagogastric junction (AEG). METHODS: This retrospective study included 258 AEG patients receiving NAC at three hospitals. Clinical and pathological data were collected. Tumor morphological and body composition parameters were quantitatively assessed on venous phase CT images at pre-treatment (Pre) and post-treatment (Post) time points. The two measurements were compared and the reduction rate (Δ%) was calculated. Multivariate Cox regression analysis was used to identify independent predictors of PFS in AEG patients and a nomogram model was developed. The incremental predictive value of tumor morphological and body composition parameters was evaluated using the concordance index (C-index), net reclassification improvement, and integrated discrimination improvement. The goodness-of-fit of models was assessed via the Akaike information criterion and χ2 likelihood ratio test. The performance of the nomogram was evaluated by the area under the time-dependent receiver operating characteristic (tdROC) curve, calibration curves, and decision curve analysis. High-risk and low-risk subgroup analyses were performed according to nomogram scores. RESULTS: Multivariate Cox regression analysis showed that ypTNM staging, Post-tumor volume, and Δ%-skeletal muscle index (SMI) were independent predictors of PFS. The nomogram incorporating these predictors demonstrated significantly superior discrimination over ypTNM staging alone in both the training cohort (C-index: 0.744; 95 % CI: 0.670-0.790; P = 0.004) and an external validation cohort (C-index: 0.738; 95 % CI: 0.615-0.807; P = 0.024). tdROC analysis showed that the nomogram achieved area under the curve (AUC) values of 0.815 and 0.791 for predicting 1- and 2-year PFS, respectively, in the training cohort. These findings were corroborated in the external validation cohort, with corresponding AUCs of 0.761 and 0.746 for 1- and 2-year PFS, respectively. Moreover, according to the score of the nomogram, patients can be effectively divided into low-risk and high-risk groups. CONCLUSION: The nomogram, incorporating ypTNM staging, Post-tumor volume, and Δ%-SMI, demonstrated robust performance in predicting PFS in AEG patients. This model significantly outperformed traditional ypTNM staging alone and may help guide personalized postoperative monitoring strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophagogastric JunctionNeoadjuvant TherapyEsophageal NeoplasmsAdenocarcinomaBody CompositionTomography, X-Ray ComputedStomach NeoplasmsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedNomogramsProgression-Free SurvivalAdultChemotherapy, Adjuvant

Stichwörter der Autor:innen

AdenocarcinomaBody compositionComputed tomographyEsophagogastric junctionNeoadjuvant therapyResponse evaluation

Autor:innen und Institutionen

  • Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052 Henan Province, China.
  • Department of Radiology, Anyang Cancer Hospital. Anyang 455000 Henan Province, China.
  • Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008 Henan Province, China.
  • Department of Radiology, Anyang Cancer Hospital. Anyang 455000 Henan Province, China. Electronic address: baby80@126.com.
  • Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008 Henan Province, China. Electronic address: lijingqingqing@163.com.
  • Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052 Henan Province, China. Electronic address: jianbogao0807@163.com.

Förderung

  • National Natural Science Foundation of China
  • Zhengzhou Municipal Science and Technology Bureau

Zitieren

APA

Luo, C., Mu, W., Zhang, H., Meng, X., Zhang, Y., Mu, Y., Yuan, M., Zhou, Y., Li, L., Ding, C., Chen, X., Li, M., Li, J., & Gao, J. (2025). Longitudinal changes in tumor morphology and body composition following neoadjuvant chemotherapy predict progression-free survival in adenocarcinoma of the esophagogastric junction: A multi-center study. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2025.112461

Vancouver

Luo C, Mu W, Zhang H, Meng X, Zhang Y, Mu Y, et al. Longitudinal changes in tumor morphology and body composition following neoadjuvant chemotherapy predict progression-free survival in adenocarcinoma of the esophagogastric junction: A multi-center study. European Journal of Radiology. 2025. doi:10.1016/j.ejrad.2025.112461

BibTeX
@article{Luo2025,
  author = {Luo, Chenglong and Mu, Wanling and Zhang, Haojie and Meng, Xinhua and Zhang, Youxin and Mu, Yusai and Yuan, Mengchen and Zhou, Yue and Li, Liming and Ding, Changmao and Chen, Xuejun and Li, Ming and Li, Jing and Gao, Jianbo},
  title = {Longitudinal changes in tumor morphology and body composition following neoadjuvant chemotherapy predict progression-free survival in adenocarcinoma of the esophagogastric junction: A multi-center study},
  journal = {European Journal of Radiology},
  year = {2025},
  doi = {10.1016/j.ejrad.2025.112461}
}
Kostenlos starten →